CIFENLINE

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	RACEMIC
Molecular Formula	C18H18N2
Molecular Weight	262.3489
Optical Activity	( + / - )
Defined Stereocenters	0 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of CIFENLINE

Structure Search

SMILES

C1C(C2=NCCN2)C1(C3=CC=CC=C3)C4=CC=CC=C4

InChI

InChIKey=IPOBOOXFSRWSHL-UHFFFAOYSA-N

InChI=1S/C18H18N2/c1-3-7-14(8-4-1)18(15-9-5-2-6-10-15)13-16(18)17-19-11-12-20-17/h1-10,16H,11-13H2,(H,19,20)

HIDE SMILES / InChI

Molecular Formula	C18H18N2
Molecular Weight	262.3489
Charge	0
Count

Stereochemistry	RACEMIC
Additional Stereochemistry	No
Defined Stereocenters	0 / 1
E/Z Centers	0
Optical Activity	( + / - )

Approval Year

Substance Class	Chemical Created by `admin` on `Fri Dec 15 15:26:08 UTC 2023` Edited by `admin` on `Fri Dec 15 15:26:08 UTC 2023`
Record UNII	Z7489237QT
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

CIFENLINE

Official Name

English

cibenzoline [INN]

Common Name

English

CIBENZOLINE

Official Name

English

RO-22-7796

Code

English

Cibenzoline [WHO-DD]

Common Name

English

1H-IMIDAZOLE, 2-(2,2-DIPHENYLCYCLOPROPYL)-4,5-DIHYDRO-, (±)-

Systematic Name

English

CIFENLINE [MI]

Common Name

English

RO 22-7796

Code

English

CIFENLINE [USAN]

Common Name

English

(±)-2-(2,2-DIPHENYLCYCLOPROPYL)-2-IMIDAZOLINE

Systematic Name

English

CIBENZOLINE [MART.]

Common Name

English

Classification Tree Code System Code

WHO-ATC

C01BG07

Created by admin on Fri Dec 15 15:26:08 UTC 2023 , Edited by admin on Fri Dec 15 15:26:08 UTC 2023

WHO-VATC

QC01BG07

Created by admin on Fri Dec 15 15:26:08 UTC 2023 , Edited by admin on Fri Dec 15 15:26:08 UTC 2023

Code System Code Type Description

FDA UNII

Z7489237QT

Created by admin on Fri Dec 15 15:26:08 UTC 2023 , Edited by admin on Fri Dec 15 15:26:08 UTC 2023

PRIMARY

EVMPD

SUB06229MIG

Created by admin on Fri Dec 15 15:26:08 UTC 2023 , Edited by admin on Fri Dec 15 15:26:08 UTC 2023

PRIMARY

SMS_ID

100000092561

Created by admin on Fri Dec 15 15:26:08 UTC 2023 , Edited by admin on Fri Dec 15 15:26:08 UTC 2023

PRIMARY

ChEMBL

CHEMBL87045

Created by admin on Fri Dec 15 15:26:08 UTC 2023 , Edited by admin on Fri Dec 15 15:26:08 UTC 2023

PRIMARY

INN

4568

Created by admin on Fri Dec 15 15:26:08 UTC 2023 , Edited by admin on Fri Dec 15 15:26:08 UTC 2023

PRIMARY

EPA CompTox

DTXSID9022819

Created by admin on Fri Dec 15 15:26:08 UTC 2023 , Edited by admin on Fri Dec 15 15:26:08 UTC 2023

PRIMARY

MERCK INDEX

m3542

Created by admin on Fri Dec 15 15:26:08 UTC 2023 , Edited by admin on Fri Dec 15 15:26:08 UTC 2023

PRIMARY

Merck Index

DRUG BANK

DB13358

Created by admin on Fri Dec 15 15:26:08 UTC 2023 , Edited by admin on Fri Dec 15 15:26:08 UTC 2023

PRIMARY

RXCUI

21099

Created by admin on Fri Dec 15 15:26:08 UTC 2023 , Edited by admin on Fri Dec 15 15:26:08 UTC 2023

PRIMARY

RxNorm

NCI_THESAURUS

C171690

Created by admin on Fri Dec 15 15:26:08 UTC 2023 , Edited by admin on Fri Dec 15 15:26:08 UTC 2023

PRIMARY

MESH

C032151

Created by admin on Fri Dec 15 15:26:08 UTC 2023 , Edited by admin on Fri Dec 15 15:26:08 UTC 2023

PRIMARY

WIKIPEDIA

Cibenzoline

Created by admin on Fri Dec 15 15:26:08 UTC 2023 , Edited by admin on Fri Dec 15 15:26:08 UTC 2023

PRIMARY

CAS

53267-01-9

Created by admin on Fri Dec 15 15:26:08 UTC 2023 , Edited by admin on Fri Dec 15 15:26:08 UTC 2023

PRIMARY

DRUG CENTRAL

630

Created by admin on Fri Dec 15 15:26:08 UTC 2023 , Edited by admin on Fri Dec 15 15:26:08 UTC 2023

PRIMARY

ECHA (EC/EINECS)

258-453-7

Created by admin on Fri Dec 15 15:26:08 UTC 2023 , Edited by admin on Fri Dec 15 15:26:08 UTC 2023

PRIMARY

PUBCHEM

2747

Created by admin on Fri Dec 15 15:26:08 UTC 2023 , Edited by admin on Fri Dec 15 15:26:08 UTC 2023

PRIMARY

USAN

S-110

Created by admin on Fri Dec 15 15:26:08 UTC 2023 , Edited by admin on Fri Dec 15 15:26:08 UTC 2023

PRIMARY

Related Record Type Details


					SEV29N8JND

POTASSIUM VOLTAGE-GATED CHANNEL SUBFAMILY H MEMBER 2

TARGET -> INHIBITOR

Qualification:

IC50

Amount:


					8E4LAA4357

CYTOCHROME P450 2D6

METABOLIC ENZYME -> SUBSTRATE


					PUO0521HZV

CYTOCHROME P450 3A4

METABOLIC ENZYME -> SUBSTRATE


					J7D38262RF

CIFENLINE, (R)-

ENANTIOMER -> RACEMATE


					38G16RWJ37

CIFENLINE SUCCINATE

SALT/SOLVATE -> PARENT


					Q3883Z4UEN

ENANTIOMER -> RACEMATE

Related Record Type Details


					Q8XZO8PG0V

4-(2-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)-1-PHENYLCYCLOPROPYL)PHENOL

METABOLITE -> PARENT

Comments:

IN VITRO; R-ISOMER IS METABOLIZED AT 23 TIMES THE RATE OF THE S-ISOMER


					KWS2KJ794X

2-(2,2-DIPHENYLCYCLOPROPYL)-1H-IMIDAZOLE

METABOLITE -> PARENT

Comments:

IN VITRO

Related Record Type Details


					Z7489237QT

CIFENLINE

ACTIVE MOIETY